Shiga Like Toxin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Molecular Templates Presents Interim Data from MT-6402

AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage.

United statesSan diegoEric pomaMolecular templates incExchange commissionAmerican association for cancer research annual meetingInterim dataCancer research annual meetingShiga like toxinLooking statementsPrivate securities litigation reform actMolecular templatesSafe harborMolecular templateNasdaq mtemMolecular templates

Molecular Templates, Inc Reports Fourth Quarter 2023 Financial Results and Business Update

AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action for cancer, today reported financial results for the fourth quarter and full year ended December 31, 2023. Company Highlights Durable s

United statesSan diegoBristol myers squibbEric pomaAmerican association for cancer researchMolecular templates incChief executiveChief scientific officerComplete responseRestated julyNasdaq capital marketAmerican associationCancer researchAnnual meetingSecond closingShiga like toxin

Molecular Templates Announces $9 5 Million Private

AUSTIN, Texas, March 28, 2024 (GLOBE NEWSWIRE) Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage.

United statesMolecular templates incExchange commissionSecurities actShiga like toxinPrivate securities litigation reform actMolecular templatesSafe harborMolecular templateNasdaq mtemMolecular templates

Molecular Templates Announces $9 5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement

Molecular Templates Announces $9 5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMolecular templates incExchange commissionTemplates announcesPrivate placement offeringAmend second trancheSecurities actShiga like toxinPrivate securities litigation reform actMolecular templatesSafe harborMolecular template

Molecular Templates To Present At Oppenheimer 34Th Annual Healthcare Life Sciences Conference

Molecular Templates To Present At Oppenheimer 34Th Annual Healthcare Life Sciences Conference
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesMolecular templates incHealthcare life sciences conferenceAnnual healthcare life sciencesAnnual healthcare conferenceVirtual presentationEastern timeShiga like toxinPrivate securities litigation reform actMolecular templatesSafe harborMolecular template